Milestone Scientific (MLSS) Non-Current Deffered Revenue (2017 - 2018)
Milestone Scientific (MLSS) posted Non-Current Deffered Revenue of $1.4 million for Q1 2018, little changed sequentially from $1.4 million in Q4 2017.
Milestone Scientific (MLSS) Non-Current Deffered Revenue (2017 - 2018) Analysis & Trends
Milestone Scientific has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $1.4 million in Q1 2018.
- Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $1.4 million in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $1.4 million (changed N/A YoY) and the FY2017 annual result came in at $1.4 million, changed N/A from the prior year.
- Non-Current Deffered Revenue held at $1.4 million in Q1 2018 per MLSS's latest filing, from $1.4 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $1.4 million in Q2 2017 and troughed at $1.4 million in Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 170.95 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 13.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 208.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Milestone Scientific | 41.18 Mn | 38.57 Mn | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 1.40 Mn |
| Dec 31, 2017 | 1.40 Mn |
| Sep 30, 2017 | 1.40 Mn |
| Jun 30, 2017 | 1.40 Mn |